Evidence map›Paper›PMID 41986792›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy.

Florian P Kirchhoff, Lisa Steinhelfer, Christian H Pfob, Constantin Lapa, Philipp E Hartrampf, Andreas K Buck, Robert Tauber, Hannah Schäfer, Christoph Schmaderer, Cornelia Fütterer and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Florian P KirchhoffDepartment of Urology, School of Medicine, Technical University of Munich, TUM University Hospital, Ismaninger Str. 22, 81675, Munich, Germany. florian.kirchhoff@tum.de.ORCID http://orcid.org/0000-0002-5144-5531
Lisa SteinhelferDepartment of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Christian H PfobFaculty of Medicine, University of Augsburg, Nuclear Medicine, Augsburg, Germany.
Constantin LapaFaculty of Medicine, University of Augsburg, Nuclear Medicine, Augsburg, Germany.
Philipp E HartrampfDepartment of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany.
Andreas K BuckDepartment of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany.
Robert TauberDepartment of Urology, School of Medicine, Technical University of Munich, TUM University Hospital, Ismaninger Str. 22, 81675, Munich, Germany.
Hannah SchäferDepartment of Nephrology, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Christoph SchmadererDepartment of Nephrology, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Cornelia FüttererSchool of Medicine and Health, Institute of AI and Informatics in Medicine, Technical University of Munich, TUM University Hospital, Munich, Germany.
Bernhard HallerSchool of Medicine and Health, Institute of AI and Informatics in Medicine, Technical University of Munich, TUM University Hospital, Munich, Germany.
Matthias JahnenDepartment of Urology, School of Medicine, Technical University of Munich, TUM University Hospital, Ismaninger Str. 22, 81675, Munich, Germany.
Karina KnorrDepartment of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Jürgen E GschwendDepartment of Urology, School of Medicine, Technical University of Munich, TUM University Hospital, Ismaninger Str. 22, 81675, Munich, Germany.
Wolfgang A WeberDepartment of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Matthias EiberDepartment of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, TUM University Hospital, Munich, Germany.
Lukas LungerDepartment of Urology, School of Medicine, Technical University of Munich, TUM University Hospital, Ismaninger Str. 22, 81675, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DocetaxelmCRPCNephrotoxicityPSMA-Lutetium I&TRadioligand therapy

Identifiers

PMID41986792
PMCPMC13315087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.